1. A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics. Issue 3 (10th August 2022) Authors: Kumthekar, Priya U; Avram, Michael J; Lassman, Andrew B; Lin, Nancy U; Lee, Eudocia; Grimm, Sean A; Schwartz, Margaret; Bell Burdett, Kirsten L; Lukas, Rimas V; Dixit, Karan; Perron, Isabella; Zhang, Hui; Gradishar, William J; Pentsova, Elena I; Jeyapalan, Suriya; Groves, Morris D; Melisko, Miche... Journal: Neuro-oncology Issue: Volume 25:Issue 3(2023) Page Start: 557 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. In pursuit of a perpetually burning flame: preventing burnout in neuro-oncology. Issue 6 (30th March 2020) Authors: Dunbar, Erin M; Kumthekar, Priya U Journal: Neuro-oncology Issue: Volume 22:Issue 6(2020) Page Start: 750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. LTBK-04. PHASE 2 MULTICENTER STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 (TASADENOTUREV) IN COMBINATION WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192). (20th November 2020) Authors: Zadeh, Gelareh; Daras, Mariza; Cloughesy, Timothy F; Colman, Howard; Kumthekar, Priya U; Chen, Clark C; Aiken, Robert; Groves, Morris D; Ong, Shirley; Ramakrishna, Rohan; Vogelbaum, Michael A; Khagi, Simon; Kaley, Thomas; Melear, Jason M; Peereboom, David M; Rodriguez, Analiz; Yankelevich, Maxim;... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗